Condition

Localized Prostate Adenocarcinoma clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Localized Prostate Adenocarcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Switzerland (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Localized Prostate Adenocarcinoma clinical trials

StudyPhaseWhereStatusRegistered
Image-guided adaptive stereotactic body radiation therapy for localized prostate cancer — Los Angeles, California Recruiting Dec 11, 2025
Feasibility of MR-Informed Adaptive Marker-less SBRT for Localized Prostate Cancer in Patients with Bilateral Hip Prostheses — Zurich, Canton of Zurich Recruiting Jun 29, 2025
Adaptive radiation therapy for localized prostate cancer — Albert Lea, Minnesota and 4 other locations Recruiting Mar 22, 2024

All recruiting trials (3)

Related topics

Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8

Quick answers

How many Localized Prostate Adenocarcinoma clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.